90953-62-1

Basic information

• Product Name: 3-hydroxy-4-methylbenzyl alcohol
• Synonyms: 3-hydroxy-4-methylbenzyl alcohol
• CAS NO: 90953-62-1
• Molecular Weight: 138.166
• Mol File: 90953-62-1.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-hydroxy-4-methylbenzyl alcohol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-hydroxy-4-methylbenzyl alcohol(90953-62-1)
• EPA Substance Registry System: 3-hydroxy-4-methylbenzyl alcohol(90953-62-1)

Safety Data

• Hazardous Substances Data: 90953-62-1(Hazardous Substances Data)

Upstream product

• 3816-66-8 3-hydroxy-4-methylbenzonitrile 
• 81863-45-8 3-(hydroxymethyl)-6-methylaniline 
• 95-87-4 2,5-Dimethylphenol 
• 67868-73-9 5-bromo-2-methylphenol methyl ether 
• 36138-76-8 5-bromo-2-methylphenol 
• 7151-68-0 3-methoxy-p-toluic acid 
• 7218-22-6 6-acetoxy-3,6-dimethyl-cyclohexa-2,4-dienone 
• 586-30-1 3-hydroxy-4-methylbenzoic acid 

Downstream Products

• 57295-30-4 3-hydroxy-4-methylbenzaldehyde 
• 1310697-12-1 ethyl 2-(5-formyl-2-methylphenoxy)acetate 
• 1369414-58-3 5-({[tert-butyl(dimethyl)silyl]oxy}methyl)-2-methylphenol 
• 92474-78-7 5-(methoxymethyl)-2-methylphenol 
• 154550-07-9 7-hydroxy-6-methyl-1,3-dihydro-2-benzofuran-1-one 
• 1416069-46-9 (3-((8-(1,3-dioxolan-2-yl)octyl)oxy)-4-methylphenyl)-methanol 

Relevant articles and documents

Pyrrolopyrazole derivative, preparation method and medical application thereof

The invention relates to pyrrolopyrazole derivative, a preparation method and application thereof in medicines. Specifically, the invention relates to a new pyrrolopyrazole derivative as shown in a general formula (I), a preparation method and application of the pyrrolopyrazole derivative or a pharmaceutical composition containing the pyrrolopyrazole derivative as a therapeutic agent, particularlyas a gastric acid secretion inhibitor and potassium-competitive acid blockers (P-CABs) in biological medicines. Specifically, the substituents (R1, R2, R3 and R4) in the general formula (I) are the same as the definitions in the specification.

Novel Compounds

The present invention provides compounds of formula (I): wherein Ra, Rb, Rc, R1, R2, R3, X1, Y1, Z1, A, n and m are as defined in the specification, and pharmaceutically acceptable salts thereof, as well as processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Compounds that modulate PPAR activity and methods of preparation

This invention discloses compounds that alter PPAR activity. The invention also discloses pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable compositions comprising the compounds or their salts, and methods of using them as therapeutic agents for treating or preventing hyperlipidemia and hypercholesteremia in a mammal. The present invention also discloses methods for making the disclosed compounds.